Fox Chase Temple Health

Fox Chase Cancer Center

This is your central portal for breaking news, the latest research and important updates from Fox Chase Cancer Center. Bookmark this page and check back often for updates.

Cover Story

Despite promising new regimens, search for cure is ‘highest priority’ in advanced renal cell carcinoma

HemOnc Today, June 25, 2019
With approximately 73,820 diagnoses and 14,770 deaths expected this year in the U.S., renal cell carcinoma remains a cancer in need of new treatment…
In the JournalsPerspective

Checkpoint inhibitor rechallenge appears safe, with monitoring, after immune-related adverse events

June 19, 2019
Readministration of anti-PD-1 or anti-PD-L1 inhibitors after mild or severe immune-related adverse events appeared to carry acceptable risks vs…
Meeting NewsPerspective

Maintenance olaparib significantly delays progression of BRCA-mutated pancreatic cancer

June 3, 2019
CHICAGO — Maintenance therapy with olaparib significantly improved PFS among patients with metastatic pancreatic cancer who harbor germline…

Fox Chase Cancer Center announces appointments

May 26, 2019
Fox Chase Cancer Center announced several faculty appointments and promotions. Michael Hall, MD, has been named chair of the department of…
Commentary

Understanding breast implant-associated anaplastic large cell lymphoma

HemOnc Today, May 25, 2019
Sameer A. Patel, MD, FACS
Cosmetic breast augmentation and implant-based breast reconstruction after mastectomy remain two of the most commonly performed surgeries by plastic…
Point/Counter

Will heparin eventually be phased out with expanded use of DOACs for VTE?

HemOnc Today, May 10, 2019
POINT Unfractionated heparin has been in use as an anticoagulant for nearly a century and LMWH for more than 3 decades. Over the last decade, we have seen…
In the Journals

Delays in radical cystectomy linked to shorter bladder cancer survival

May 8, 2019
Delays in radical cystectomy appeared associated with increased mortality among patients with muscle-invasive bladder cancer, regardless of whether…
In the Journals

Transfers of breast cancer care lead to treatment delays that may impact outcomes

April 26, 2019
Women with newly diagnosed breast cancer who transferred care between institutions risked delays in surgery or other forms of treatment, which could…
In the Journals

Autologous HSCT extends PFS among young patients with mantle cell lymphoma

March 11, 2019
Consolidative autologous hematopoietic stem cell transplantation after induction chemotherapy significantly improved PFS among younger patients with…

Thomas Jefferson to negotiate with Temple for acquisition of Fox Chase Cancer Center

January 10, 2019
Thomas Jefferson University and Temple University have started negotiations regarding a potential acquisition of Fox Chase Cancer Center. Jefferson…

Fox Chase Cancer Center researcher receives American Cancer Society grant

December 16, 2018
American Cancer Society’s Pennsylvania/New Jersey Pay-If Research Council has awarded Jaye Gardiner, PhD, a $163,500 grant to support research…
Meeting NewsPerspective

Gut microbial diversity before stem cell transplantation may impact survival

December 13, 2018
SAN DIEGO — Higher gut microbial diversity was associated with improved survival in a multinational cohort of patients undergoing hematopoietic…
In the Journals Plus

Stereotactic radiosurgery comparable to surgical resection for local control of brain metastases

November 21, 2018
Stereotactic radiosurgery appeared comparable to surgical resection for controlling local brain metastases, according to an exploratory analysis of a…
Cover Story

Advances in myeloma treatments, diagnostics have specialists ‘talking about cure’

HemOnc Today, November 25, 2018
A decade ago, patients with newly diagnosed multiple myeloma typically survived 3 to 5 years. However, the development of highly effective therapies…
In the Journals PlusGuidelines

Guideline supports shorter radiation therapy option in prostate cancer

November 14, 2018
The American Society for Radiation Oncology, ASCO and the American Urological Association have published a guideline supporting moderately…
Molecular Oncology

Recent advances push forward the field of molecular oncology

HemOnc Today, October 10, 2018
Wafik S. El-Deiry, MD, PhD, FACP
A number of recent advances in molecular oncology are noteworthy for our new regular column, which launched in September. Here is an overview of…
Molecular Oncology

Translating an explosion of knowledge in molecular oncology

HemOnc Today, September 10, 2018
Wafik S. El-Deiry, MD, PhD, FACP
There have been many advances in the molecular analysis of cancer in recent years, with an explosion of knowledge that can be daunting and rapid…

Fox Chase Cancer Center appoints general surgery division chief

September 9, 2018
Jeffrey Farma, MD, has been appointed chief of the division of general surgery within the department of surgery at Fox Chase Cancer Center. Farma, a…
Commentary

Erroneous reporting vs. erroneous interpretation of liquid biopsy results

HemOnc Today, August 10, 2018
Wafik S. El-Deiry, MD, PhD, FACP
As the co-chair of the oral abstract session on tumor biology at this year’s ASCO Annual Meeting, I was particularly looking forward to a…

Fox Chase Cancer Center appoints assistant professor

August 8, 2018
Kristen Whitaker, MD, has been appointed assistant professor in the department of clinical genetics at Fox Chase Cancer Center. Whitaker will treat…